Stay updated on ELVN-002 in HER2 NSCLC Clinical Trial
Sign up to get notified when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.

Latest updates to the ELVN-002 in HER2 NSCLC Clinical Trial page
- Check2 days agoChange DetectedThis page shows a minor revision update from v3.4.0 to v3.4.1; no changes to core content or study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0; older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were replaced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedMinor site revision from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations updated: new sites across multiple countries added and some existing sites removed; page revision updated to v3.3.3.SummaryDifference1%

- Check74 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This appears to be a minor internal version update with no impact on study content or user-facing features.SummaryDifference0.0%

- Check81 days agoChange DetectedThe study site list now includes Tainan, Taiwan, replacing Tainan City, Taiwan, and the government funding status notice was removed.SummaryDifference0.3%

Stay in the know with updates to ELVN-002 in HER2 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.